In his new book, “Phake: The Deadly World of Falsified and Substandard Medicines,” Roger Bate explores the underground trade in illegal medicines that kills over 100,000 people per year and supplants billions of dollars of real products.

Drug prices have recently become less expensive with the spread of generic versions, but Medicaid support seems to make drugs more expensive.

Controls would take away the industry's incentive to develop new lifesaving medications and therapies.

Knowing where all our ingredients come from is the first step toward improving drug quality.

Scholars from AEI and elsewhere answer key questions about Medicare drug coverage and government controls.

Reports from AARP and Families USA have heightened concerns among policymakers and the public about the affordability of prescription drugs. However, those reports are misleading.

Murray Aitken, vice president of IMS Health, the world's largest source of drug-price and sales data, and MIT professor Ernst Berndt will explain why their research shows that average drug prices for seniors have declined, not increased, by more than 20 percent.

Medicare Part D — delivering prescription drugs to seniors — has been a success since President Bush introduced it. And the Obama administration plans to threaten that achievement.